Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study
荷兰(2017-2024 年)接受 UGT1A1 基因型指导的伊立替康给药治疗的结直肠癌或胰腺癌患者的生存情况:一项回顾性多中心队列研究
期刊:Lancet Regional Health-Europe
影响因子:13
doi:10.1016/j.lanepe.2026.101629
Peeters, Sofía L J; Heersche, Niels; Böhm, Doortje; Böhringer, Stefan; Guiljam, Roselien; Hulshof, Emma C; de Man, Femke M; de With, Mirjam; Joosse, Marije; Oomens, Gysella; Wu, Qiong-Yi; Osman, Aisha; Bins, Sander; van Hellemond, Irene E G; Haberkorn, Brigitte C M; Verschoor, Arjan J; Wumkes, Miriam L; van Schaik, Ron H N; Thijs, Anna M; Gelderblom, Hans; Guchelaar, Henk-Jan; Mathijssen, Ron H J; Deenen, Maarten J